This inventor holds 19 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Antibacterial Compounds. Top assignees: Merck Sharp + Dohme Corp., Halozyme, Inc., Lawrence Livermore National Security, LLC. Active years: 2006-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 2,405 
4 out of 85 
4 out of 1,629 
Years Active: 2006-2026
Areas of Expertise:
Title: Innovations and Contributions of Xiaoming Li in Antibacterial Research
Introduction
Xiaoming Li, based in San Diego, CA, is a prominent inventor known for his significant contributions to the field of antibacterial compounds. With a total of 18 patents to his name, Li has made noteworthy advancements in pharmaceuticals aimed at inhibiting the growth of harmful bacteria.
Latest Patents
Li's recent patents showcase his innovative work in developing antibacterial compounds. One of his notable inventions involves heterocyclic derivative compounds and pharmaceutical compositions that inhibit the growth of gram-negative bacteria. These compounds are heralded for their potential in treating bacterial infections, including urinary tract infections. Another of his recent patents focuses on heterocyclic compounds and their pharmaceutically acceptable salts, outlining methods of use that span therapeutics, diagnostics, and research tools. Specifically, these compositions denote a capacity to reduce the signaling output of oncogenic proteins, showcasing their versatility and importance in medical research.
Career Highlights
Throughout his career, Xiaoming Li has been associated with respected companies in the pharmaceutical sector, including Halozyme, Inc. and Merck Sharp & Dohme Corporation. His work at these organizations has significantly contributed to the development of novel medical treatments and therapies that address critical health challenges.
Collaborations
Collaboration has played a key role in Li's research initiatives. He has worked alongside esteemed colleagues, such as Zhiyong Chen and Thanh To Lam, fostering an environment of innovation and shared knowledge that has propelled their collective work in drug development.
Conclusion
Xiaoming Li's inventive spirit and dedication to research in antibacterial compounds continue to impact the field of pharmaceuticals positively. His contributions not only enhance therapeutic options available for bacterial infections but also pave the way for future innovations in medical science. With each patent, Li is setting a benchmark for excellence in the ongoing battle against antibiotic-resistant pathogens.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile